Evaluation Value of Preoperative Serum Transaminase Ratio Combined with Serum Tumor Markers for Prognosis of Patients with Stage III Colorectal Cancer: A Retrospective Study.

作者：Xiaodong Li, Zhao Wu, Fei Cheng, Lebin Yuan, Weiyang Xia, Zhigang Li, Zeyu Huang, Shengping Mao, Xing Chen, Wei Feng Shen · 发表于：PubMed · 年份：2025 · 研究领域：Cancer, Lipids, and Metabolism、Colorectal Cancer Treatments and Studies、Cancer, Stress, Anesthesia, and Immune Response

OBJECTIVE: This study utilized data from two hospitals to investigate the relationship between the preoperative serum alanine aminotransferase to aspartate aminotransferase ratio (LSR) combined with preoperative serum tumor markers (TM) and the prognosis of patients with stage III colorectal cancer (CRC). METHODS: -value of less than 0.05 considered statistically significant. RESULT: =0.002). CONCLUSION: 1. The prognosis of patients with high preoperative LSR and low CEA, CA199 in perioperative period is better than that of other stage III colorectal cancer patients. 2. Perioperative preoperative serum transaminase ratio combined with CEA, CA199 has a certain reference value in the prognosis assessment of stage III colorectal cancer.